 | • レポートコード：QFJ1-3830 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗腫瘍薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン＆拮抗薬、微生物製品、植物製品、抗腫瘍抗生物質、アルキル化剤、代謝拮抗剤、天然物）、用途別市場規模（肺がん、膀胱がん、乳がん、子宮頸がん、白血病、婦人科がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗腫瘍薬の市場動向 ・企業の競争状況、市場シェア ・抗腫瘍薬の種類別市場規模と予測2016-2027（ホルモン＆拮抗薬、微生物製品、植物製品、抗腫瘍抗生物質、アルキル化剤、代謝拮抗剤、天然物） ・抗腫瘍薬の用途別市場規模と予測2016-2027（肺がん、膀胱がん、乳がん、子宮頸がん、白血病、婦人科がん、その他） ・抗腫瘍薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗腫瘍薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗腫瘍薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗腫瘍薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗腫瘍薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline plc.、F. Hoffmann-La Roche Ltd、Eli Lilly and Company、Bristol-Myers Squibb Company、Becton, Dickinson and Company、Pfizer Inc.、Novartis AG、AstraZeneca、Gilead） ・結論 |
Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.
Market Analysis and Insights: Global Anti-Neoplastic Pharmaceutical Agents Market
The global Anti-Neoplastic Pharmaceutical Agents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Neoplastic Pharmaceutical Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Neoplastic Pharmaceutical Agents market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Neoplastic Pharmaceutical Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Neoplastic Pharmaceutical Agents market.
Global Anti-Neoplastic Pharmaceutical Agents Scope and Market Size
Anti-Neoplastic Pharmaceutical Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Neoplastic Pharmaceutical Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hormones and Antagonists
Microorganism Products
Plant Products
Antitumor Antibiotics
Alkylating Agents
Antimetabolites
Natural Products
Segment by Application
Lung Cancer
Bladder Cancer
Breast Cancer
Cervical Cancer
Leukemia
Gynecological Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Pfizer Inc.
Novartis AG
AstraZeneca
Gilead
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormones and Antagonists
1.2.3 Microorganism Products
1.2.4 Plant Products
1.2.5 Antitumor Antibiotics
1.2.6 Alkylating Agents
1.2.7 Antimetabolites
1.2.8 Natural Products
1.3 Market by Application
1.3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Lung Cancer
1.3.3 Bladder Cancer
1.3.4 Breast Cancer
1.3.5 Cervical Cancer
1.3.6 Leukemia
1.3.7 Gynecological Cancer
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Perspective (2016-2027)
2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Regions
2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Neoplastic Pharmaceutical Agents Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Neoplastic Pharmaceutical Agents Industry Dynamic
2.3.1 Anti-Neoplastic Pharmaceutical Agents Market Trends
2.3.2 Anti-Neoplastic Pharmaceutical Agents Market Drivers
2.3.3 Anti-Neoplastic Pharmaceutical Agents Market Challenges
2.3.4 Anti-Neoplastic Pharmaceutical Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue
3.1.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue (2016-2021)
3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
3.4 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio
3.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Pharmaceutical Agents Revenue in 2020
3.5 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served
3.6 Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
3.7 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Type
4.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2016-2021)
4.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2022-2027)
5 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Application
5.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Application (2016-2021)
5.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
6.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type
6.2.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
6.2.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
6.2.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
6.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application
6.3.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
6.3.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
6.3.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
6.4 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country
6.4.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021)
6.4.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
7.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type
7.2.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
7.2.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
7.2.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application
7.3.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
7.3.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
7.3.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
7.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country
7.4.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021)
7.4.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
8.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type
8.2.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application
8.3.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region
8.4.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
9.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type
9.2.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
9.3 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application
9.3.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
9.4 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country
9.4.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
10.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type
10.2.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application
10.3.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country
10.4.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc.
11.1.1 GlaxoSmithKline plc. Company Details
11.1.2 GlaxoSmithKline plc. Business Overview
11.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Introduction
11.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.1.5 GlaxoSmithKline plc. Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Introduction
11.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Details
11.5.2 Becton, Dickinson and Company Business Overview
11.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Introduction
11.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.5.5 Becton, Dickinson and Company Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Details
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Introduction
11.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.6.5 Pfizer Inc. Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Introduction
11.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Introduction
11.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Gilead
11.9.1 Gilead Company Details
11.9.2 Gilead Business Overview
11.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Introduction
11.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
11.9.5 Gilead Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormones and Antagonists
Table 3. Key Players of Microorganism Products
Table 4. Key Players of Plant Products
Table 5. Key Players of Antitumor Antibiotics
Table 6. Key Players of Alkylating Agents
Table 7. Key Players of Antimetabolites
Table 8. Key Players of Natural Products
Table 9. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2016-2021)
Table 13. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2022-2027)
Table 15. Anti-Neoplastic Pharmaceutical Agents Market Trends
Table 16. Anti-Neoplastic Pharmaceutical Agents Market Drivers
Table 17. Anti-Neoplastic Pharmaceutical Agents Market Challenges
Table 18. Anti-Neoplastic Pharmaceutical Agents Market Restraints
Table 19. Global Anti-Neoplastic Pharmaceutical Agents Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players (2016-2021)
Table 21. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2020)
Table 22. Ranking of Global Top Anti-Neoplastic Pharmaceutical Agents Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
Table 26. Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2016-2021)
Table 30. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Application (2016-2021)
Table 34. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027) & (US$ Million)
Table 66. GlaxoSmithKline plc. Company Details
Table 67. GlaxoSmithKline plc. Business Overview
Table 68. GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Product
Table 69. GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline plc. Recent Development
Table 71. F. Hoffmann-La Roche Ltd Company Details
Table 72. F. Hoffmann-La Roche Ltd Business Overview
Table 73. F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Product
Table 74. F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 75. F. Hoffmann-La Roche Ltd Recent Development
Table 76. Eli Lilly and Company Company Details
Table 77. Eli Lilly and Company Business Overview
Table 78. Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Product
Table 79. Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 80. Eli Lilly and Company Recent Development
Table 81. Bristol-Myers Squibb Company Company Details
Table 82. Bristol-Myers Squibb Company Business Overview
Table 83. Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Product
Table 84. Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 85. Bristol-Myers Squibb Company Recent Development
Table 86. Becton, Dickinson and Company Company Details
Table 87. Becton, Dickinson and Company Business Overview
Table 88. Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Product
Table 89. Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 90. Becton, Dickinson and Company Recent Development
Table 91. Pfizer Inc. Company Details
Table 92. Pfizer Inc. Business Overview
Table 93. Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Product
Table 94. Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 95. Pfizer Inc. Recent Development
Table 96. Novartis AG Company Details
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Anti-Neoplastic Pharmaceutical Agents Product
Table 99. Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 100. Novartis AG Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 104. AstraZeneca Recent Development
Table 105. Gilead Company Details
Table 106. Gilead Business Overview
Table 107. Gilead Anti-Neoplastic Pharmaceutical Agents Product
Table 108. Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
Table 109. Gilead Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Type: 2020 VS 2027
Figure 2. Hormones and Antagonists Features
Figure 3. Microorganism Products Features
Figure 4. Plant Products Features
Figure 5. Antitumor Antibiotics Features
Figure 6. Alkylating Agents Features
Figure 7. Antimetabolites Features
Figure 8. Natural Products Features
Figure 9. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2027
Figure 10. Lung Cancer Case Studies
Figure 11. Bladder Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Cervical Cancer Case Studies
Figure 14. Leukemia Case Studies
Figure 15. Gynecological Cancer Case Studies
Figure 16. Other Case Studies
Figure 17. Anti-Neoplastic Pharmaceutical Agents Report Years Considered
Figure 18. Global Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions: 2020 VS 2027
Figure 21. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2022-2027)
Figure 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players in 2020
Figure 23. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue in 2020
Figure 25. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2016-2021)
Figure 26. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2022-2027)
Figure 27. North America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
Figure 29. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
Figure 30. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2016-2027)
Figure 31. United States Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
Figure 35. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
Figure 36. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2016-2027)
Figure 37. Germany Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Share by Region (2016-2027)
Figure 47. China Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
Figure 55. Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
Figure 56. Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2016-2027)
Figure 57. Mexico Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2016-2027)
Figure 63. Turkey Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. GlaxoSmithKline plc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 67. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 68. Eli Lilly and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 69. Bristol-Myers Squibb Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 70. Becton, Dickinson and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 71. Pfizer Inc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 72. Novartis AG Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 73. AstraZeneca Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 74. Gilead Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の抗腫瘍療法市場規模・現状・予測（2021年-2027年） Anti-neoplastic therapy refers to the therapy which aims to prevent, inhibit or halt the development of a neoplasm. Market Analysis and Insights: Global Anti-Neoplastic Therapy Market The global Anti-Neoplastic Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in …- 植物源抗がん剤のグローバル市場調査 2019年 The global Plant Sources Anti Cancer Agents market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Plant Sources Anti Cancer Agents volume and value at global level, regional level and company level. From …
- 植物源抗がん剤のグローバル市場調査 2019年 The global Plant Sources Anti Cancer Agents market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Plant Sources Anti Cancer Agents volume and value at global level, regional level and company level. From …
- アスファルト剥離防止剤のグローバル市場2021 Anti-stripping agents are often overlooked when boosting the performance of asphalt. It is added to asphalt to increase the occurrence and strength of asphalt-aggregate adhesion The technical barriers of Asphalt Anti-Stripping Agents are relatively high, resulting in high level concentration degree.…
- 肥料用固結防止剤のグローバル市場2021 Caking is a significant concern in dry fertilizer production, storage, transport and application. Anti-caking agent can prevent agglomeration of fertilizer, inhibit fertilizer moisture and powder, and enhance particle mobility. Anti-Caking Agents for Fertilizer downstream is wide and recently Anti-C…